Denali Therapeutics announces Phase 1B Study of DNL747
Drug Discovery | News | 0 Comment | 11 Jan, 2019
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...Read more
Japan approves Amgen's osteoporosis drug
Drug Discovery | News | 0 Comment | 10 Jan, 2019
Amgen and UCB announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...Read more
Daiichi Sankyo receives regulatory approval for hypertension tablets
Drug Discovery | News | 0 Comment | 10 Jan, 2019
Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...Read more
Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy
Drug Discovery | News | 0 Comment | 09 Jan, 2019
Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...Read more
Oculis raises CHF 15.5 million
Drug Discovery | News | 0 Comment | 08 Jan, 2019
Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...Read more
AbbVie and Tizona Therapeutics announce strategic collaboration
Drug Discovery | News | 0 Comment | 04 Jan, 2019
Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...Read more
Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients
Drug Discovery | News | 0 Comment | 04 Jan, 2019
Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...Read more
AstraZeneca announces phase III trials for roxadustat
Drug Discovery | News | 0 Comment | 03 Jan, 2019
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...Read more
Lupin gets FDA approval for Clobazam oral suspension
Drug Discovery | News | 0 Comment | 01 Jan, 2019
Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United S...Read more
Teva brings Generic Elidel Cream, 1% in US market
Drug Discovery | News | 0 Comment | 01 Jan, 2019
Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus)...Read more
BeiGene initiates clinical trial of Tislelizumab with cancer patients
Drug Discovery | News | 0 Comment | 31 Dec, 2018
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...Read more
Chugai obtains approval for Genomic Mutation Analysis Program
Drug Discovery | News | 0 Comment | 27 Dec, 2018
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...Read more
Cannabics files patent for personalized cannabimetic compositions modeling, production
Drug Discovery | News | 0 Comment | 27 Dec, 2018
Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effec...Read more
I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2
Drug Discovery | Company results | 6 Comment | 24 Dec, 2018
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...Read more
Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership
Drug Discovery | News | 0 Comment | 20 Dec, 2018
Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...Read more
Lexicon Pharma announces positive topline clinical data for LX9211
Drug Discovery | News | 0 Comment | 19 Dec, 2018
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...Read more
Bridge Bio signs $40M license agreement with Daewoong Pharma
Drug Discovery | News | 0 Comment | 19 Dec, 2018
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...Read more
FibroGen's roxadustat OK'd in China
Drug Discovery | News | 0 Comment | 18 Dec, 2018
Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...Read more